Precipitous fall in platelet count with anagrelide: case report and critique of dosing recommendations--a comment.
Petitt
R M
RM
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
D004334:Drug Administration Schedule; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced*
D010975:Platelet Aggregation Inhibitors; D011799:Quinazolines; C021139:anagrelide